org placeholder image

Dennis Riley

CSO at Galera Therapeutics

  • LinkedIn

Email Email: d****@galeratx.com

phone noPhone Number: (***)-***-****

map
GALERA THERAPEUTICS

GALERA THERAPEUTICS

  • description Description
    Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
  • Employees count Employees 11-50
  • Revenue Revenue 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Galera Therapeutics Org Chart and Mapping

VP-Level
Employees

Robert Beardsley

Co-Founder, Executive Chair and Chief Operating Officer

Elizabeth Turner

Vice President of Market Access

Jeffery Keene

Consultant - Pharm and Tox

Kara Terry

Director, Clinical Development

Adrianne Rush

Associate Director, Project Management, Quality and Regulatory Systems

Gail Zanecosky

Controller Galera Therapeutics, Inc.

Ted Everson

Senior Director, Medical Affairs

Eileen Romich

Administrative Assistant

Frequently Asked Questions Regarding Dennis Riley

Answer: Dennis Riley works for Galera Therapeutics as CSO

Answer: Dennis Riley’s role in Galera Therapeutics is CSO

Answer: Dennis Riley's email address is d***@gmail.com

Answer: Dennis Riley's business email address is d****@galeratx.com

Answer: Dennis Riley’s direct phone number is (***)-***-****

Answer: Dennis Riley works in the industry of: Pharmaceuticals

Answer: Dennis Riley works Galera Therapeutics located at 2 W Liberty BLVD Ste 100, Malvern, Pennsylvania, 19355, United States

Answer: Galera Therapeutics's CSO is Dennis Riley

Answer: Dennis Riley contact details:

  • Phone number  :  (***)-***-****
  • Email  :  d****@galeratx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access